4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0000950170-24-138629
Chief Financial Officer sold 18,709 shares at an average $41.21 ($770,912)
- Chief Financial Officer gave up 6,625 shares (to pay taxes)
- Chief Financial Officer acquired 25,334 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
AULIN SHERRY · Chief Financial Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-12-18 | Exercise or conversion : show line 1 in the form | +9,334 | $9.44 | $88,113 | 9,334 | D |
| 2024-12-18 | Shares withheld for taxes : show line 2 in the form | −2,135 | $41.28 | $88,133 | 7,199 | D |
| 2024-12-18 | Sale : show line 3 in the form | −7,199 | $41.23 | $296,815 | 0 | D |
| 2024-12-18 | Exercise or conversion : show line 4 in the form | +16,000 | $11.58 | $185,280 | 16,000 | D |
| 2024-12-18 | Shares withheld for taxes : show line 5 in the form | −4,490 | $41.28 | $185,347 | 11,510 | D |
| 2024-12-18 | Sale : show line 6 in the form | −11,510 | $41.19 | $474,097 | 0 | D |
| Open-market sales · 18,709 sh · avg $41.21 · $770,912 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-12-18 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −9,334 | 0 | D |
| 2024-12-18 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −16,000 | 6,000 | D |
Loading xslF345X05/ownership.xml…